Xia Zhi-Yu, Zhang Si-Han, Sun Jian-Xuan, Wang Shao-Gang, Xia Qi-Dong
Department and Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Discov Oncol. 2024 Sep 27;15(1):472. doi: 10.1007/s12672-024-01387-1.
Focal therapy, a minimally invasive strategy for localized prostate cancer, has been widely employed in the targeted treatment of localized prostate cancer in recent years. We analyzed 1312 relevant papers from the last decade using Web of Science Core Collection data. Our analysis covered countries, institutions, journals, authors, keywords, and references to offer a multifaceted perspective on the development of this field. The U.S. led in publications, contributing over half of the top 10 institutions. Emberton, M from University College London was the most published and cited author. "EUROPEAN UROLOGY" was the top journal by impact factor in 2022. Analysis of references and keywords suggests the prevalence of brachytherapy-related research, while high-intensity focused ultrasound (HIFU), cryotherapy, and irreversible electroporation (IRE) are emerging as new research focuses. Consequently, more high-quality evidence is necessary to evaluate the long-term effectiveness and safety of these novel therapeutic methods.
聚焦治疗作为一种针对局限性前列腺癌的微创策略,近年来已广泛应用于局限性前列腺癌的靶向治疗。我们使用科学网核心合集数据,分析了过去十年间的1312篇相关论文。我们的分析涵盖了国家、机构、期刊、作者、关键词和参考文献,以便从多方面审视该领域的发展。美国在论文发表数量上领先,前10大机构中有超过半数来自美国。伦敦大学学院的恩伯顿·M是发表论文数量最多且被引用次数最多的作者。《欧洲泌尿外科杂志》是2022年影响因子最高的期刊。对参考文献和关键词的分析表明,近距离放射治疗相关研究较为普遍,而高强度聚焦超声(HIFU)、冷冻疗法和不可逆电穿孔(IRE)正成为新的研究热点。因此,需要更多高质量证据来评估这些新型治疗方法的长期有效性和安全性。